Increased resistance and depressed delayed-type hypersensitivity to Listeria monocytogenes induced by pretreatment with lipopolysaccharide.
AUTOR(ES)
Galleli, A
RESUMO
Intravenous injection of a small dose of lipopolysaccharide 24 h before infection with Listeria monocytogenes enhanced the resistance of mice to this organism. This protective effect of lipopolysaccharide related to the ability of nonimmune macrophages to inhibit bacterial proliferation in livers and spleens. Surprisingly, lipopolysaccharide-treated mice exhibited inferior acquired immunity, as measured by adoptive transfer of immunity to normal mice, delayed-type hypersensitivity to Listeria antigens, and uptake of tritiated thymidine by lymphocytes in the spleen. These results support the view that lipopolysaccharide stimulates a highly effective anti-Listeria immunity via the macrophage component, despite interference with the lymphocyte component.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=351755Documentos Relacionados
- Suppression of the delayed-type hypersensitivity and cell-mediated immune responses to Listeria monocytogenes induced by Pseudomonas aeruginosa.
- Decreased delayed-type hypersensitivity and increased protection to Listeria monocytogenes seen in mice infected with mucoid and nonmucoid Pseudomonas aeruginosa.
- Expression of systemic protection and delayed-type hypersensitivity to Listeria monocytogenes is mediated by different T-cell subsets.
- Delayed-type hypersensitivity and immunity to Salmonella typhimurium.
- Dissociation between delayed-type hypersensitivity and resistance to pathogenic mycobacteria demonstrated by T-cell clones.
